Diagnosis

CXCR4 Mutation Analysis

Sanger sequencing of CXCR4 c-terminal mutations associated with ibrutinib resistance in Waldenström's macroglobulinemia.

CXCR4 Mutation Analysis2026-05-03T16:03:03-07:00

DEK::NUP214 t(6;9)

Quantitative RQ-PCR detection and monitoring of the t(6;9)(p22;q34) DEK::NUP214 fusion transcript in AML.

DEK::NUP214 t(6;9)2026-05-03T16:03:03-07:00

ETV6::RUNX1 t(12;21)

Quantitative RQ-PCR detection of the t(12;21) ETV6::RUNX1 (TEL::AML1) fusion, associated with favorable prognosis in ALL.

ETV6::RUNX1 t(12;21)2026-05-03T16:03:03-07:00

FIP1L1::PDGFRA del(4q12)

Quantitative RQ-PCR detection of the FIP1L1::PDGFRA fusion from interstitial 4q12 deletion in HES and chronic eosinophilic leukemia.

FIP1L1::PDGFRA del(4q12)2026-05-03T16:03:03-07:00

FLT3 ITD/TKD Mutation Analysis

PCR fragment analysis with EcoRV digest detecting FLT3 internal tandem duplications (ITD) and D835 tyrosine kinase domain mutations in AML.

FLT3 ITD/TKD Mutation Analysis2026-05-03T16:03:03-07:00

IDH1 Mutation Analysis

Sanger sequencing of IDH1 exon 4 mutations including R132 to inform IDH inhibitor treatment decisions.

IDH1 Mutation Analysis2026-05-03T16:03:03-07:00

IDH2 Mutation Analysis

Sanger sequencing of IDH2 exon 4 mutations at codons R140 and R172 to inform IDH inhibitor treatment decisions.

IDH2 Mutation Analysis2026-05-03T16:03:03-07:00

B-Cell IGH Gene Rearrangement

PCR fragment-length analysis detecting clonal IGH rearrangements (FR1, FR2, FR3) for B-cell lymphoma diagnosis and monitoring.

B-Cell IGH Gene Rearrangement2026-05-03T16:03:03-07:00
Go to Top